Olanzapine for the treatment of borderline personality disorder: Variable dose 12-week randomised double-blind placebo-controlled study

S. Charles Schulz, Mary C. Zanarini, Anthony Bateman, Martin Bohus, Holland C. Detke, Quynh Trzaskoma, Yoko Tanaka, Daniel Lin, Walter Deberdt, Sara Corya

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Fingerprint Dive into the research topics of 'Olanzapine for the treatment of borderline personality disorder: Variable dose 12-week randomised double-blind placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences